Filing Details
- Accession Number:
- 0001401708-21-000227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-19 16:11:25
- Reporting Period:
- 2021-11-17
- Accepted Time:
- 2021-11-19 16:11:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401708 | Nanostring Technologies Inc | NSTG | Biological Products, (No Disgnostic Substances) (2836) | 200094687 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1432055 | Thomas K Bailey | 530 Fairview Avenue N Seattle WA 98109 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-17 | 5,937 | $8.16 | 5,937 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-11-17 | 1,906 | $23.34 | 7,843 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-17 | 7,365 | $46.68 | 478 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-17 | 478 | $47.66 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-11-17 | 5,937 | $8.16 | 5,937 | $8.16 |
| Common Stock | Stock Options (right to buy) | Disposition | 2021-11-17 | 1,906 | $23.34 | 1,906 | $23.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,959 | 2028-01-15 | No | 4 | M | Direct | |
| 10,167 | 2029-03-25 | No | 4 | M | Direct |
Footnotes
- The sales reported by Mr. Bailey were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2020.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $46.24 to $47.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $47.25 to $48.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- 25% of the shares subject to the Option vest on the one-year anniversary of January 16, 2018 (the "Option Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the Vesting Commencement Date.
- 1/48 of the shares subject to such option shall vest on the one-month anniversary of March 13, 2019 (the "Option Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Option Vesting Commencement Date becoming fully vested on the four-year anniversary of the Option Vesting Commencement Date.
Billionaire Hedge Funds
